Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01129856 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Study of EGP-437 (Dexamethasone Phosphate Formulated for Ocular Iontophoresis) to Treat Dry Eye
A Phase 3 study, sponsored by Eyegate Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 198
- Enrollment target
NCT01129856: Completed Phase 3 study, sponsored by Eyegate Pharmaceuticals.
NCT01129856 is a Phase 3 study that has completed, run by Eyegate Pharmaceuticals. The registered enrollment target is 198 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01129856, a Phase 3 study, has completed, sponsored by Eyegate Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 198 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and efficacy of EGP-437 (dexamethasone phosphate formulated for ocular iontophoresis) using the EyeGate® II Iontophoresis system in patients with dry eye.
Interventions
- DRUG Dexamethasone phosphate ophthalmic solution
- DRUG Sodium citrate buffer solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-04 |
| Phase | Phase 3 |
What the finished NCT01129856 record still lists
NCT01129856 is an interventional study that assigns participants to a tested intervention. The registered 198 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone phosphate ophthalmic solution is the first listed.
NCT01129856 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01129856 about?
NCT01129856 is a clinical study titled "Safety and Efficacy Study of EGP-437 (Dexamethasone Phosphate Formulated for Ocular Iontophoresis) to Treat Dry Eye". The purpose of this study is to assess the safety and efficacy of EGP-437 (dexamethasone phosphate formulated for ocular iontophoresis) using the EyeGate® II Iontophoresis system in patients with dry eye.
What is the current status of trial NCT01129856?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 198 participants. The study started on 2010-06. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01129856?
The interventions under investigation include: Dexamethasone phosphate ophthalmic solution (DRUG), Sodium citrate buffer solution (DRUG).
Who is sponsoring clinical trial NCT01129856?
This trial is sponsored by Eyegate Pharmaceuticals, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01129856's enrollment target sits among peer trials
198 1389th of 2000 higher than 611 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05203328 · 198 participants · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- NCT05426967 · 198 participants · NA
rTMS for Military TBI-related Depression
- NCT05561114 · 198 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
- NCT05585190 · 198 participants · NA
Stand Up for Your Health with a Sit-stand Desk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia